LncRNA-p21 alters the antiandrogen enzalutamide-induced prostate cancer neuroendocrine differentiation via modulating the EZH2/STAT3 signaling
Jie Luo(University of Rochester), Chawnshang Chang(University of Rochester Medical Center)
Cited by 223
Related Papers
Abnormal Mammary Gland Development and Growth Retardation in Female Mice and MCF7 Breast Cancer Cells Lacking Androgen Receptor
|The Journal of Experimental Medicine|2003|148
Metformin Inhibits Nuclear Receptor TR4–Mediated Hepatic Stearoyl-CoA Desaturase 1 Gene Expression With Altered Insulin Sensitivity
|Diabetes|2011|97
The MAO inhibitors phenelzine and clorgyline revert enzalutamide resistance in castration resistant prostate cancer
|Nature Communications|2020|92
Tissue Prostate-Specific Antigen Facilitates Refractory Prostate Tumor Progression via Enhancing ARA70-Regulated Androgen Receptor Transactivation
|Cancer Research|2008|87
Induction of the Intronic Enhancer of the Human Ciliary Neurotrophic Factor Receptor (CNTFRä) Gene by the TR4 Orphan Receptor
|Journal of Biological Chemistry|1997|60